Response to ‘Adverse cardiac outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors’
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2021
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Cardiovascular System & Hematology (Science Metrix)
- Chronic Disease (MeSH)
- Humans (MeSH)
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive (MeSH)
- Protein Kinase Inhibitors (MeSH)
published in
- Heart Journal